Sysmex picks neighbouring Asian CTC firm for liquid biopsy collaboration
This article was originally published in Clinica
Executive Summary
Japanese hematology diagnostics heavyweight Sysmex is partnering with Clearbridge BioMedics, an emerging Singapore company in the field of circulating tumor cell capture technology, to co-develop a new liquid biopsy system for diagnosing and monitoring cancer patients.